|
|
Summaries of Product Characteristics (SPC) for Human medicinal products
The summaries of product characteristics (SPC) contain the information relevant to the use of the medicinal products and of importance to health care professionals. The SPCs are published in Finnish; the use of Finnish key words in the search fields is therefore recommended.
Some of the medicinal products contain a condition relevant to the prescribing of the product and not always found in the SPC. The conditions for prescribing and the products covered by this condition are found in the FimeaWeb search.
The SPCs processed as part of the EU centralised marketing authorisation procedure are published by the European Medicines Agency, EMA. Fimea's service contains links to the documents on medicinal products (EPAR PI) on the EMA website. Drugs belonging to the centralised authorisation procedure can be searched in Fimea's service by using an alphabetical list or by entering the product name or ATC code.
The material being published is not necessarily complete or up-to-date due to the technical quality of files submitted to the Finnish Medicines Agency Fimea or earlier to the National Agency for Medicines and the delays in delivery. For this reason, Fimea cannot guarantee that the document on the Internet fully complies with the summary of product characteristics and package leaflet officially approved by a desicion for a marketing authorisation. Only the hard copies of the SPCs and the PLs, which are in accordance with the marketing authorisation, are conclusive.
| Summaries of Product Characteristics 151 - 180 of 448 |
|
|
|
Package
leaflet | Status for
supply | Name of the medicinal product |
|
|
|
European Medicines Agency's website:
Alli (ent. Orlistat GSK) - EMA: EPAR PI
Finnish Swedish
|
|
PL
|
Resepti
|
Allonol 100 mg, 300 mg tabletti SPC 2023-04-14
|
|
PL
|
Resepti
|
Allopurinol Accord 100 mg, 300 mg tabletti SPC 2024-01-26
|
|
PL
|
Resepti
|
Allopurinol Orion 100 mg tabletti SPC 2022-11-09
|
|
PL
|
Resepti
|
Allopurinol Orion 300 mg tabletti SPC 2022-11-09
|
|
PL
|
Resepti
|
Alluzience 200 Speywood-yksikköä - ml, injektioneste, liuos SPC 2023-03-23
|
|
PL
|
Resepti
|
Almogran 12,5 mg tabletti SPC 2020-11-19
|
|
|
|
European Medicines Agency's website:
Alofisel - EMA: EPAR PI
Finnish Swedish
|
|
PL
|
Itsehoito
|
Alomide 1 mg-ml silmätipat, liuos SPC 2022-08-18
|
|
|
|
European Medicines Agency's website:
Aloxi - EMA: EPAR PI
Finnish Swedish
|
|
PL
|
Resepti
|
Alphagan 0,2 prosenttia (2 mg-ml) silmätipat, liuos SPC 2022-03-16
|
|
PL
|
Resepti
|
Alprazolam Krka 0.5 mg, 1 mg, 2 mg depottabletti SPC 2022-04-12
|
|
|
|
European Medicines Agency's website:
Alprolix - EMA: EPAR PI
Finnish Swedish
|
|
|
|
European Medicines Agency's website:
Alprolix - EMA: EPAR PI
Finnish Swedish
|
|
PL
|
Resepti
|
Alprox 0.25 mg, 0.5 mg, 1 mg tabletti SPC 2023-06-16
|
|
PL
|
Resepti
|
Altermol 500 mg-30 mg tabletti SPC 2023-12-05
|
|
|
|
European Medicines Agency's website:
Alunbrig - EMA: EPAR PI
Finnish Swedish
|
|
PL
|
Resepti
|
Alutard SQ Epiteelit injektioneste, suspensio SPC 2022-04-25.doc
|
|
PL
|
Resepti
|
Alutard SQ Huonepölypunkit injektioneste, suspensio. SPC 2022-11-25
|
|
PL
|
Resepti
|
Alutard SQ Hyönteismyrkyt injektioneste, suspensio, SPC 2021-06-03
|
|
PL
|
Resepti
|
Alutard SQ Siitepölyt injektioneste, suspensio, koivu, SPC 2021-10-13
|
|
PL
|
Resepti
|
Alutard SQ Siitepölyt injektioneste, suspensio, timotei, SPC 2022-10-06
|
|
PL
|
Resepti
|
Alvesco 160 mikrog/annos inhalaatiosumute, liuos SPC 2022-03-09
|
|
PL
|
Resepti
|
Alvesco 80 mikrog/annos inhalaatiosumute, liuos SPC 2022-03-09
|
|
|
|
European Medicines Agency's website:
Alymsys - EMA: EPAR PI
Finnish Swedish
|
|
PL
|
Resepti
|
Amaryl 1 mg, 2 mg, 3 mg, 4 mg tabletti SPC 2022-10-19
|
|
|
|
European Medicines Agency's website:
Ambirix - EMA: EPAR PI
Finnish Swedish
|
|
PL
|
Resepti
|
AmBisome liposomal 50 mg infuusiokuiva-aine, dispersiota varten SPC 2024-02-26
|
|
PL
|
Resepti
|
Ambrisentan Accord 5 mg, 10 mg tabletti, kalvopäällysteinen SPC 2023-01-18
|
|
|
|
European Medicines Agency's website:
Ambrisentan Mylan - EMA: EPAR PI
Finnish Swedish
|
|
|
| |
